Plebani M. The changing face of clinical laboratories. Clin Chem Lab Med 1999; 37:711–7. [Crossref]
Gray TA. Clinical governance. Ann Clin Biochem 2000; 37:9–15. [Crossref]
Plebani M. Role of inspectors in external review mechanisms: criteria for selection, training and appraisal. Clin Chim Acta 2001; 309:147–54.
Price CP. Evidence-based laboratory medicine: supporting decision-making. Clin Chem 2000; 46:1041–50.
Waise A, Plebani M. Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome? Ann Clin Biochem 2001; 38:589–95. [Crossref]
Konh LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC: Academic Press, 2000.
Plebani M, Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem 1997; 43:1348–51.
Bonini PA, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002; 48:691–8.
Stroobants AK, Goldschmidt HM, Plebani M. Error budget calculations in laboratory medicine: linking the concepts of biological variation and allowable medical errors. Clin Chim Acta 2003; 333:169–76.
Holman JW, Mifflin TE, Felder RA, Demers LM. Evaluation of an automated preanalytical robotic workstation at two academic health centers. Clin Chem 2002; 48:540–8.
Ricos C, Garcia-Victoria M, de la Fuente B. Quality indicators and specifications for the extra-analytical phases in clinical laboratory management. Clin Chem Lab Med 2004; 42:578–82. [Crossref]
Draft Federal Information Processing Standards Publication 183. Integration definition for function modelling (idef). www.Idef.com/Downloads/pdf/idef0.pdf, 1993.
Redmill F, Chudleigh M, Catmur J. System safety: HAZOP and Software HAZOP. Chichester: John Wiley & Sons, 1999.
Schraagen JM, Chipman SF, Shalin VL. Cognitive task analysis. Mahwah, NJ: Lawrence Erlbaum Associates, 2000.
Bonini P, Ceriotti F, Gaia M. Total laboratory error: inevitable or avoidable. Clin Chim Acta 2005; 355:s46–7.
Proposed ISO/DTR 22367. Medical laboratories – reduction of error through risk management and continual improvement – complementary element. Version 2.1c2. ISO, 2005.
Jones BA, Calam RR, Howanitz PJ. Chemistry specimen acceptability. Arch Pathol Lab Med 1997; 121:19–26.
Field MJ, Lohr KN, editors. Guidelines for clinical practice. From development to use. Washington, DC: National Academy Press, 1992.
Oosterhuis WP, Bruns DE, Watine J, Sandberg S, Horvath AR. Evidence-based guidelines in laboratory medicine: principles and methods. Clin Chem 2004; 50:806–18. [Crossref]
Demers EM, Spencer CA. Laboratory support for the diagnosis and monitoring of thyroid disease. The National Academy of Clinical Biochemistry, 2003 (http://www.nacb.org/lmpg/thyroid_lmpg_pub.stm).
Hamm CW, Bertrand M, Braunwald E. Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet 2001; 358:1533–8.
Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002; 117:316–24.
ISO 15189. Medical laboratories – particular requirements for quality and competence. ISO, 2003. [Web of Science]
Laposata M. Patient-specific narrative interpretation of complex clinical laboratory evaluations: who is competent to provide them? Clin Chem 2004; 50:471–2. [Crossref]
Kilpatrick ES. Can the addition of interpretative comments to laboratory reports influence outcome? An example involving patients taking thyroxine. Ann Clin Biochem 2004; 41:227–9. [Crossref]
Fraser CG, Hyltoft Petersen P. Analytical performance characteristics should be judged against objective quality specifications. Clin Chem 1999; 45:321–3.
Plebani M. What information on quality specifications should be communicated to clinicians, and how? Clin Chim Acta 2004; 346:25–35.
Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance. Rev Clin Exp Hematol 2002; 63:225–52. [Crossref]
Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000; 46:306–7.
Wilson ML. Appropriate use of clinical microbiology tests. Clin Lab Med 2002; 22:491–503. [Crossref]
Toybert ME, Chevret S, Cassinat B, Schlageter MH, Beressi JP, Rain JD. From guidelines to hospital practice: reducing inappropriate ordering of thyroid hormone and antibody tests. Eur J Endocrinol 200; 142:605–10.
Keren DF. Antinuclear antibody testing. Clin Lab Med 2002; 22:447–74. [Crossref]
Howanitz PG, Tetrault GA, Steindel SJ. Clinical laboratory quality control: a costly process now out of control. Clin Chim Acta 1997; 260:163–74.
Henny J, Petersen HP. Reference values: from philosophy to a tool for laboratory medicine. Clin Chem Lab Med 2004; 42:686–91. [Crossref]
Grasbeck R. The evolution of the reference value concept. Clin Chem Lab Med 2004; 42:692–7. [Crossref]
Plebani M. Charting the course of medical laboratories in a changing environment. Clin Chim Acta 2002; 319:87–100.
Fraser CG. Inherent biological variation and reference values. Clin Chem Lab Med 2004; 42:758–64. [Crossref]
Forsman RW. Why is the laboratory an afterthought for managed care organizations? Clin Chem 1996; 42:813–6.
Provonost PJ, Nolan T, Zeger S, Miller M, Rubin H. How can clinicians measure safety and quality in acute care? Lancet 2004; 363:1061–7.
Plebani M. Towards quality specifications in extra-analytical phases of laboratory activity. Clin Chem Lab Med 2004; 42:578–82. [Crossref]